Skip to main content
. 2015 Mar 16;80(3):589–598. doi: 10.1111/bcp.12626

Table 1.

Definition of low, moderate and high risk of a UGIE in each cohort

UGIE risk group Definition in LDA cohort Definition in NSAID cohort
High risk At least one of the following high risk factors: At least one of the following high risk factors:
History of UGIE History of UGIE
Age ≥ 80 Age ≥ 70
Age 70–79 and ≥ one other moderate risk factor ≥ Two moderate risk factors
Age 60–69 and ≥ two moderate risk factors
Moderate risk No high risk and at least one of the following moderate risk factors: No high risk and at least one of the following moderate risk factors:
Age 70–79 Age 60–69 years
Use of VKA History of DM
Use of clopidogrel History of HF
Use of a corticosteroid History of severe RA
Use of SSRI Use of VKA
Use of spironolactone Use of LDA
Use of clopidogrel
Use of a corticosteroid
Use of an SSRI
Use of spironolactone
High-dose NSAID
Low risk No moderate or high risk No moderate or high risk

DM, diabetes mellitus; HF, heart failure; LDA, low-dose aspirin; NSAID, non-steroidal anti-inflammatory drug; RA, rheumatoid arthritis; SSRI, serotonin-reuptake inhibitor; UGIE, upper gastrointestinal event; VKA, vitamin K antagonist.